Market carnage followed healthcare reform in March for the home healthcare industry.   Public company shareholders didn't appreciate $40B in proposed cuts to Medicare reimbursements.  Mergers & acquisitions initially surged, as consolidatation became a necessity, but several prominent deals then stalled due to restrictions on transfers imposed by the 36-month rule.

In the past few weeks, however, mergers, acquisitions, and market perception have rebounded.  Gentiva Health Services Inc. (GTIV) are up sharply. The strength is primarily due to the fact that GTIV reached an agreement over the weekend to acquire Odyssey Healthcare Inc. (ODSY) for $27.00 in cash, a premium that reflects shareholder confidence that strategic transactions of this type will drive new growth and profits.

The overly-expansive provisions introduced to the 36 month rule in December were also rescinded in the past few weeks.  While revised provisions are expected to be introduced any day, they are predicted to include a small fraction of the prior restrictions.  As a result, many of the private buyers and equity groups who have been waiting on the sidelines are now aggressively pursuing home heatlhcare targets again.